Ulcerative colitis Trials in Nagpur, India
Conditions / Ulcerative colitis / Nagpur, India
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02914522 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT02914535 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | COMPLETED | PHASE3 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT05507203 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | COMPLETED | PHASE3 |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03996369 | Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03524092 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |